The IFITM Proteins Inhibit HIV-1 Infection
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Type I interferon protects cells from virus infection through the induction of a group of genes collectively named interferon-stimulated genes (ISGs). In this study, we utilized short hairpin RNA (shRNA) to deplete ISGs in SupT1 cells in order to identify ISGs that suppress the production of human immunodeficiency virus type 1 (HIV-1). Among the ISG candidates thus identified were interferon-induced transmembrane (IFITM) proteins, including IFITM1, IFITM2, and IFITM3, that potently inhibit HIV-1 replication at least partially through interfering with virus entry. Further mutagenesis analysis shows that the intracellular region, rather than the N- and C-terminal extracellular domains, is essential for the antiviral activity of IFITM1. Altogether, these data suggest that the IFITM proteins serve as important components of the innate immune system to restrict HIV-1 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TET2 is a DNA dioxygenase that demethylates the IFITM3 promoter during viral infection, inhibiting HIV Env trafficking and reducing viral spread61,62.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947 · cited 3×
“Plasmacytoid dendritic cells, the major interferon producers, release large quantities of interferon, partially through recognition of HIV-1 RNA by TLR7 (23).”
BackgroundIsolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569 · cited 1×
“However, we subsequently noted that TZM-bl, which is a HeLa-derived HIV-1 indicator cell line (65), expresses considerable amounts of IFITM2 and IFITM3 proteins (Fig.”
BackgroundBrass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Mercer, J., Schelhaas, M., & Helenius, A. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-104626 · Cited by 1,057
Van Damme, N., Goff, D., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., & Guatelli, J. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.001 · Cited by 1,050
HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
Miyauchi, K., Kim, Y., Latinovic, O., Morozov, V., & Melikyan, G. B. (2009) · Cell · doi:10.1016/j.cell.2009.02.046 · Cited by 681
HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
Host Innate Immune Receptors and Beyond: Making Sense of Microbial Infections
Ishii, K. J., Koyama, S., Nakagawa, A., Coban, C., & Akira, S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.003 · Cited by 499
Dynamics of HIV-1 recombination in its natural target cells
Levy, D. N., Aldrovandi, G. M., Kutsch, O., & Shaw, G. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306764101 · Cited by 441
Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L., & Tedder, T. F. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.9.2841 · Cited by 402
Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients
Soumelis, V., Scott, I., Gheyas, F., Bouhour, D., Cozon, G., Cotte, L., Huang, L., Levy, J. A., & Liu, Y.-J. (2001) · Blood · doi:10.1182/blood.v98.4.906 · Cited by 398
Donaghy, H., Pozniak, A., Gazzard, B., Qazi, N., Gilmour, J., Gotch, F., & Patterson, S. (2001) · Blood · doi:10.1182/blood.v98.8.2574 · Cited by 393
Palmitoylome profiling reveals S-palmitoylation–dependent antiviral activity of IFITM3
Yount, J. S., Moltedo, B., Yang, Y.-Y., Charron, G., Moran, T. M., López, C. B., & Hang, H. C. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.405 · Cited by 367
Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15
Okumura, A., Lu, G., Pitha-Rowe, I., & Pitha, P. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510518103 · Cited by 363
Jiang, D., Weidner, J. M., Qing, M., Pan, X.-B., Guo, H., Xu, C., Zhang, X., Birk, A., Chang, J., Shi, P.-Y., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02199-09 · Cited by 337
Interferon-α But Not AZT Suppresses HIV Expression in Chronically Infected Cell Lines
Poli, G., Orenstein, J. M., Kinter, A., Folks, T. M., & Fauci, A. S. (1989) · Science · doi:10.1126/science.2470148 · Cited by 328
RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO
Ho, D., Rota, T., Kaplan, J., Hartshorn, K., Andrews, C., Schooley, R., & Hirsch, M. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92144-0 · Cited by 305
Jiang, D., Guo, H., Xu, C., Chang, J., Gu, B., Wang, L., Block, T. M., & Guo, J.-T. (2008) · Journal of Virology · doi:10.1128/jvi.02113-07 · Cited by 288
Weidner, J. M., Jiang, D., Pan, X.-B., Chang, J., Block, T. M., & Guo, J.-T. (2010) · Journal of Virology · doi:10.1128/jvi.01328-10 · Cited by 285
The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22
Barr, S. D., Smiley, J. R., & Bushman, F. D. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000007 · Cited by 276
Kornbluth, R. S., Oh, P. S., Munis, J. R., Cleveland, P. H., & Richman, D. D. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.3.1137 · Cited by 270
Lane, H. C., Davey, V., Kovacs, J. A., Feinberg, J., Metcalf, J. A., Herpin, B., Walker, R., Deyton, L., Davey, R. T., Falloon, J., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-11-805 · Cited by 228
Activation of host pattern recognition receptors by viruses
Brennan, K., & Bowie, A. G. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.007 · Cited by 178
HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation
Okumura, A., Alce, T., Lubyova, B., Ezelle, H., Strebel, K., & Pitha, P. M. (2008) · Virology · doi:10.1016/j.virol.2007.10.042 · Cited by 166
Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle
Shirazi, Y., & Pitha, P. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1321-1328.1992 · Cited by 161
APOBEC3G Inhibits DNA Strand Transfer during HIV-1 Reverse Transcription
Li, X., Guo, F., Zhang, L., Kleiman, L., & Cen, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703423200 · Cited by 161
Chen, K., Huang, J., Zhang, C., Huang, S., Nunnari, G., Wang, F., Tong, X., Gao, L., Nikisher, K., & Zhang, H. (2006) · Journal of Virology · doi:10.1128/jvi.00206-06 · Cited by 161
Bril: A Novel Bone-Specific Modulator of Mineralization
Moffatt, P., Gaumond, M.-H., Salois, P., Sellin, K., Bessette, M.-C., Godin, É., de Oliveira, P. T., Atkins, G. J., Nanci, A., & Thomas, G. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080412 · Cited by 154
The Interferon-Induced Gene ISG15 Blocks Retrovirus Release from Cells Late in the Budding Process
Pincetic, A., Kuang, Z., Seo, E. J., & Leis, J. (2010) · Journal of Virology · doi:10.1128/jvi.02478-09 · Cited by 149
Yamamoto, J. K., Barré‐Sinoussi, F., Bolton, V., Pedersen, N. C., & Gardner, M. B. (1986) · Journal of Interferon Research · doi:10.1089/jir.1986.6.143 · Cited by 148
Identification of the IFITM Family as a New Molecular Marker in Human Colorectal Tumors
Andreu, P., Colnot, S., Godard, C., Laurent‐Puig, P., Lamarque, D., Kahn, A., Perret, C., & Romagnolo, B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2731 · Cited by 143
York, J., & Nunberg, J. H. (2006) · Journal of Virology · doi:10.1128/jvi.00642-06 · Cited by 137
Doehle, B., Hladik, F., McNevin, J. P., McElrath, M. J., & Gale, M. (2009) · Journal of Virology · doi:10.1128/jvi.00849-09 · Cited by 136
Gendelman, H. E., Baca, L. M., Turpin, J. A., Kalter, D. C., Hansen, B. D., Orenstein, J. M., Dieffenbach, C. W., Friedman, R. M., & Meltzer, M. S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.8.2669 · Cited by 135
Goujon, C., & Malim, M. H. (2010) · Journal of Virology · doi:10.1128/jvi.00854-10 · Cited by 135
Normal Germ Line Establishment in Mice Carrying a Deletion of the Ifitm/Fragilis Gene Family Cluster
Lange, U. C., Adams, D. J., Lee, C., Barton, S., Schneider, R., Bradley, A., & Surani, M. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00272-08 · Cited by 128
Hartshorn, K. L., NEUMEYER, D., Vogt, M. W., et al. (1987) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1987.3.125 · Cited by 125
Bednarik, D. P., Mosca, J. D., Raj, N. B., & Pitha, P. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4958 · Cited by 113
Cell entry by human pathogenic arenaviruses
Rojek, J. M., & Kunz, S. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01113.x · Cited by 109
Alpha Interferon Enhances TRIM5α-Mediated Antiviral Activities in Human and Rhesus Monkey Cells
Sakuma, R., Mael, A. A., & Ikeda, Y. (2007) · Journal of Virology · doi:10.1128/jvi.00419-07 · Cited by 105
Tetherin: Holding On and Letting Go
Sauter, D., Specht, A., & Kirchhoff, F. (2010) · Cell · doi:10.1016/j.cell.2010.04.022 · Cited by 97
The role of interferons in the control of HIV replication in macrophages
Kornbluth, R. S., Oh, P., Munis, J. R., Cleveland, P. H., & Richman, D. D. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90082-2 · Cited by 94
Evans, S., Lee, D., Han, T., et al. (1990) · Blood · doi:10.1182/blood.v76.12.2583.2583 · Cited by 83
Yu, J. J., Wu, T. L., Liszewski, M. K., Dai, J., Swiggard, W. J., Baytop, C., Frank, I., Levine, B. L., Yang, W. P., Theodosopoulos, T. V., et al. (2008) · Virology · doi:10.1016/j.virol.2008.05.030 · Cited by 82
Martensen, P. M., & Justesen, J. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/107999004772719864 · Cited by 78
Multiple effects of interferon on the replication of human immunodeficiency virus type 1
Pitha, P. M. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90068-x · Cited by 77
Regulation of Human Immunodeficiency Virus Replication by 2′,5′-Oligoadenylate-Dependent RNase L
Maitra, R. K., & Silverman, R. H. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1146-1152.1998 · Cited by 76
Shirazi, Y., & Pitha, P. M. (1993) · Virology · doi:10.1006/viro.1993.1126 · Cited by 75
IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells
Evans, S. S., Collea, R. P., Leasure, J. A., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.3.736 · Cited by 74
Seyfried, N. T., Huysentruyt, L. C., Atwood, J., Xia, Q., Seyfried, T. N., & Orlando, R. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.007 · Cited by 69
Hansen, B. D., Nara, P. L., Maheshwari, R. K., Sidhu, G. S., Bernbaum, J. G., HOEKZEMA, D. T., Meltzer, M. S., & Gendelman, H. E. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7543-7548.1992 · Cited by 67
York, J., & Nunberg, J. H. (2006) · Virology · doi:10.1016/j.virol.2006.08.048 · Cited by 66
Lichtner, M., Rossi, R., Mengoni, F., Vignoli, S., Colacchia, B., Massetti, A. P., Kamga, I., Hosmalin, A., Vullo, V., & Mastroianni, C. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02994.x · Cited by 61
Restriction of HIV Replication in Infected T Cells and Monocytes by Interferon-α
Gendelman, H. E., Baca, L. M., Turpin, J. A., et al. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.1045 · Cited by 59
York, J., & Nunberg, J. H. (2007) · Journal of Virology · doi:10.1128/jvi.01785-07 · Cited by 59
Francis, M. L., & Meltzer, M. S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2208 · Cited by 57
Smith, R. A., Young, J. C., Weis, J. J., et al. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364278 · Cited by 57
Inhibition of Growth of HIV by Human Natural Interferon In Vitro
Yamada, O., Hattori, N., Kurimura, T., et al. (1988) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1988.4.287 · Cited by 53
Agy, M. B., ACKER, R. L., SHERBERT, C. H., et al. (1995) · Virology · doi:10.1006/viro.1995.0047 · Cited by 53
HIV replication can be blocked by recombinant human interferon beta
Michaelis, B., & Levy, J. A. (1989) · AIDS · doi:10.1097/00002030-198901000-00006 · Cited by 50
Inhibition of proliferation by 1-8U in interferon-α-responsive and non-responsive cell lines
Brem, R., Oroszlan‐Szovik, K., Foser, S., Bohrmann, B., & Certa, U. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3016-9 · Cited by 49
Fluorescence Resonance Energy Transfer-Based HIV-1 Virion Fusion Assay
Cavrois, M., Neidleman, J. A., Bigos, M., & Greene, W. C. (2004) · Humana Press eBooks · doi:10.1385/1-59259-773-4:333 · Cited by 46
Skillman, D. R., Malone, J. L., Decker, C. F., Wagner, K., Mapou, R. L., Liao, M.-J., Testa, D., & Meltzer, M. S. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.5.1107 · Cited by 45
HIV replication can be blocked by recombinant human interferon beta
Michaelis, B., & Levy, J. A. (1989) · AIDS · doi:10.1097/00002030-198903010-00006 · Cited by 40
Fernández‐Cruz, E., Lang, J.-M., Frissen, P. H. J., et al. (1995) · PubMed · Cited by 31
Interferon Inhibits the Replication of HIV-1, SIV, and SHIV Chimeric Viruses by Distinct Mechanisms
Korth, M. J., Taylor, M. D., & Katze, M. G. (1998) · Virology · doi:10.1006/viro.1998.9249 · Cited by 24
Effects of IFNα on late stages of HIV-1 replication cycle
Dianzani, F., Castilletti, C., Gentile, M., Gelderblom, H., Frezza, F., & Capobianchi, M. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80028-5 · Cited by 24
Nagai, K., Wong, A. H.-T., Li, S., Tam, W., Cuddihy, A. R., Sonenberg, N., Mathews, M. B., Hiscott, J. B., Wainberg, M. A., & Koromilas, A. E. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1718-1725.1997 · Cited by 22
Use of recombinant interferon-α in Human Immunodeficiency Virus (HIV)-infected individuals
Rivero, J., Limonta, M., Aguilera, A., Fraga, M., & Saura, P. L. (1994) · Biotherapy · doi:10.1007/bf01878118 · Cited by 21
Cited by
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Interferon-stimulated genes and their antiviral effector functions
Schoggins, J. W., & Rice, C. M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.008 · Cited by 1,289
The broad-spectrum antiviral functions of IFIT and IFITM proteins
Diamond, M. S., & Farzan, M. (2013) · Nature Reviews Immunology · doi:10.1038/nri3344 · Cited by 849
Interferon-inducible effector mechanisms in cell-autonomous immunity
MacMicking, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3210 · Cited by 579
IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
Bailey, C. C., Zhong, G., Huang, I.-C., & Farzan, M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085537 · Cited by 467
Metadata
- Authors
- Lu, J., Pan, Q., Rong, L., Liu, S.-L., & Liang, C.
- Affiliations
- Jewish General Hospital (CA)
- McGill University (CA)
- Corresponding author
- Liang, Chen
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2011-03
- Volume
- 85
- Issue
- 5
- Pages
- 2126-2137
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3067758
- OpenAlex
- W2077620427
- Cited by
- 417
- References
- 74
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 23 · 2023: 19 · 2022: 33 · 2021: 25 · 2020: 21 · 2019: 27 · 2018: 28 · 2017: 49 · 2016: 19 · 2015: 29 · 2014: 33 · 2013: 40 · 2012: 25
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Update notices
- correction (2011-03-15)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Foundation for AIDS Research
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- HIV-1 infection, interferon-stimulated genes, type I interferon, antiviral innate immunity, HIV-1 entry inhibition, IFITM1, IFITM2, IFITM3, SupT1 cells, shRNA knockdown, antiviral activity
- MeSH terms
- Amino Acid Sequence, Antigens, Differentiation, Cell Line, Humans, Membrane Proteins, Molecular Sequence Data, Virus Replication, HIV-1, Down-Regulation, HIV Infections, Sequence Alignment, RNA-Binding Proteins, Protein Structure, Tertiary, Virus Internalization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.